The clinical features and pharmacokinetics of omeprazole in overdose have not previously been described. We report 2 cases. The major clinical features were flushing, tachycardia and headache. Omeprazole pharmacokinetics remained unchanged in overdose.
Get full access to this article
View all access options for this article.
References
1.
Lagerström P-O. & Persson B-A.Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. Journal of Chromatography1984; 309: 347-56.
2.
Committee on Safety of Medicines.Diarrhoea, skin reactions and headache following omeprazole therapy. Current Problems Number 31. June 1991.
3.
Simon TJ & Bradstreet DCComparative tolerability profile of omeprazole in clinical trials. Digestive Diseases and Science1991; 36: 1384-9.
4.
Pritchard PJ , Yeomans ND, Mihaly GW et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology1985; 88: 64-9.
5.
Andersson T. , Cederberg C., Edvardsson G., Heggelund A. & Lundborg P.Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clinical Pharmacology and Therapeutics1990; 47: 79-85.
